The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMerchants Trust Regulatory News (MRCH)

Share Price Information for Merchants Trust (MRCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 569.00
Bid: 565.00
Ask: 567.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.354%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 569.00
MRCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

27 Sep 2021 07:00

RNS Number : 9740M
Merchants Trust PLC
27 September 2021
 

LEI: 5299008VJFXCUD2EG312

 

THE MERCHANTS TRUST PLC

Half-Yearly Financial Report

For the six months ended 31 July 2021

 

 

 

 

 

 

Interim management report

 

Net asset value - a year makes a big difference

I am pleased to be reporting on a period of very positive performance for the trust, both in an absolute sense but also relative to the benchmark index. At the half-way point last year we were having to report on a difficult six months, however as outlined in the latest annual report, the second half of the year brought relief with a considerable recovery and boost for many of the companies held in the portfolio. Over the six months to the end of July, Merchant's NAV total return (with debt at fair value) was 19.8%, very comfortably ahead of the benchmark return of 12.6%. This strong performance continued the recovery that started in the second half of the previous financial year. The ongoing recovery is being led by strong pockets of recovery from the effects of the pandemic and in the UK in particular, the apparent efficacy of the national vaccination programme.

 

Gearing - strategy holding firm

In the first half of the current financial year, financial gearing has amplified the portfolio's positive return. We remain confident in the strategy of maintaining gearing on the portfolio, believing it helps to achieve a level of outperformance over the long term where expected returns are ahead of the cost of debt. Gearing at the period end was 14.1% (31 July 2020: 20.9%).

 

A value rally

Some of the market performance we witnessed earlier in the year was attributed to a so-called rotation from growth into value in terms of favoured investment style in the market and consequently this favoured Merchants' portfolio where the manager follows a value philosophy. It should be noted however that the performance of the portfolio is not predicated solely on a 'recovery' in the share prices of what we feel are undervalued stocks. A recent quote from the trust's manager sums this up well - when asked "value or growth?", he responded "I would categorise myself as a value investor, meaning that the price I pay for an asset is a critical part of my investment process. However, value is not the opposite of growth. Ideally, I like to own companies that can grow fast, provided I can buy them at a sensible price." This is important to underline when reporting on a period of positive performance where a 'macro' market style rotation lifted many 'value' stocks simultaneously. Merchants' philosophy is not simply about buying cheap shares and waiting for such a rally or overarching market recovery. Rather it is about owning quality companies, backed by sound fundamental research, but not overpaying for those shares. Whilst many market pundits can be heard asking 'how long' the value rally might last, or whether it has already run its course, our manager remains focused on finding solid companies to invest in, with continuing depressed valuations simply providing additional opportunity. Ultimately, we hope that the market returns to valuing companies according to their underlying financial metrics but, while pricing inefficiencies remain, the portfolio stands to benefit from attractive entry points to good companies.

 

Earnings recovery (in part)

As well as a general recovery in market valuations, we are pleased to see a return to companies paying dividends. The recovery has been strong, although not to pre-COVID levels, with many companies taking the opportunity to rebase payments to a lower starting point. The portfolio revenue earnings per share (EPS) for the six months were up 49% over the corresponding period last year to 13.3p (2020: 8.9p), but this still lags the (pre-COVID) 2019 figure of 16.1p. As payment of income is typically biased to the first half of the year (including for the new European shares now held in the portfolio), we do not necessarily expect the second half of the year to provide as high a level of earnings, however portfolio earnings continue to recover from the very low base level last year caused by the effects of the pandemic.

 

Against this backdrop the trust's revenue reserves continue to provide a practical buffer to allow the flexibility to draw on them to support our key objective of paying a high and rising dividend to shareholders. As at 31 July 2021 revenue reserves were 17.6p per share (2020: 22.6p). It remains likely that we will have to call further on reserves this year as earnings continue to recover, but our manager maintains an optimistic outlook on dividends in the market over the coming years and, ultimately, a scenario where we return to a covered dividend and can begin rebuilding reserves once more.

 

Dividends

The board has declared a second quarterly dividend of 6.8p per ordinary share, payable on 11 November 2021 to shareholders on the register at close of business on 8 October 2021. A Dividend Reinvestment Plan ('DRIP') is available for this dividend for which the relevant Election Date is 21 October 2021 and the ex-dividend date is 7 October 2021.

 

For the first half of this financial year the dividend has been maintained at a consistent level with 2020, with a total distribution declared of 13.6p. As noted in the latest annual report, the board remains committed to the payment of a progressive dividend to shareholders, having now raised the dividend for 39 consecutive years and being one of the AIC's 'Dividend Heroes', an elite group of investment trust companies that have increased their dividends each year for 20 years or more.

 

A changing landscape

As shareholders will hopefully be aware, the board authorised the manager earlier this year to invest up to 10% of the portfolio in overseas listed securities. The aims of the slight shift are to allow the manager more flexibility to diversify the portfolio, to seek new diverse sources of income and to access sectors where there are limited or no opportunities in the UK market. At the end of the reporting period the portfolio had around 4% invested in overseas shares and in particular this flexibility has allowed access to the re-insurance sector, with more detail being given in the investment management report.

 

Market demand

We have witnessed continuing demand this year for the company's shares and this has led to periods where we have taken advantage of the authority to issue new shares at a premium to Net Asset Value (NAV). This improves the company's liquidity, modestly enhances NAV and limits the premium of our shares to the NAV. So far this fiscal year 3,745,000 new shares have been issued and no shares have been bought back. We continue to market to professional investors through a coordinated programme of meetings and events, as well as to private investors through relevant websites, publications and events.

 

Shareholder contact

As always, we encourage shareholders to visit our website in between reporting periods to view updates from our investment manager and to register to receive email updates when they are available.

 

The 2021 AGM was once again held as a virtual and closed event given the ongoing restrictions at the time. We hope to be able to meet with shareholders in person again in the not-too-distant future.

 

We are pleased to report that this year's annual report once again won the AIC's Shareholder Communications Award for Best Report & Accounts (Generalist). We hope shareholders feel as the judges did that our reporting is both accessible and useful to you as investors.

 

Simon Fraser

Shareholders may have heard by now of the sad passing of Simon Fraser. Simon was chairman of the Merchants board from 2010 to 2019, when I took the baton from him. Simon was a man of great judgment, wisdom and integrity and a beacon in the investment management industry. He was generous of his time and was very passionate about Merchants. The board acknowledges and thanks Simon for his contribution to Merchants and the wider industry and our thoughts are very much with his family and all others affected by this sad loss.

 

Outlook

The world remains a strange place. Some days one might be forgiven for thinking we were 'back to normal' whilst other times we are issued stark reminders of the ongoing pandemic which we are very much still struggling to get to grips with on a global scale. Economic recovery, whilst positive, is also bringing with it the spectre of rising inflation as governments throw the weight of policy behind supporting their economies and input prices rise. Markets seem to be acting in a reasonably stoic manner though and for some time now the question around recovery seems to have been one of trajectory and timescale rather than 'if'.

 

As manager Simon Gergel notes in his investment review on page 9 of the printed report, one certainty at the moment is that the UK stock market remains considerably cheaper than major global peers, even with the removal of political and Brexit uncertainty that has caused downward pressure over the past five years or so. In addition, there remains further apparently indiscriminate pressure on any company not viewed as high growth by the market. Ultimately this all spells opportunity for skilled stockpickers and should provide a good hunting ground for the investment manager to maintain a portfolio which can meet Merchants' long term objectives of capital growth plus a high and rising income for investors.

 

 

 

Colin Clark

Chairman

199 Bishopsgate

London EC2M 3TY

 

24 September 2021

 

Principal Risks and Uncertainties

As identified in the Annual Report, the board has maintained close contact with the manager and other third party service providers to understand their approaches to the COVID-19 pandemic and actions taken to mitigate the effects of the pandemic on the company and its business and their plan for future working arrangements.

 

The principal risks and uncertainties facing the company, together with the board's controls and mitigation, are those described in the Annual Report for the year ended 31 January 2021 published in April 2021 and are listed below:

 

· Investment strategy and investment performance; and

· Emerging risks which continue to have elements of uncertainty, including those caused by the COVID-19 pandemic and Brexit implementation are still significant but are better understood and mitigated than they were in 2020.

 

The board's approach to mitigating these risks and uncertainties is set out in the explanation with the Risk Map in the Annual Report. In the board's view these will remain the principal risks and uncertainties for the six months to 31 January 2022.

 

Going Concern

The directors have considered the company's investment objective and capital structure and having noted that the portfolio is liquid as it consists mainly of securities which are readily realisable, and through continuous assessment of the company's financial covenants, have concluded that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have also considered the continuing risks and consequences of the COVID-19 pandemic and have concluded that the company has the ability to continue in operation and meet its objectives in the foreseeable future. For this reason, the directors continue to adopt the going concern basis in preparing the financial statements.

 

Responsibility Statements

The directors confirm to the best of their knowledge that:

 

· The condensed set of financial statements contained within the half-yearly financial report has been prepared in accordance with FRS102 and FRS104, as set out in Note 2, the Accounting Standards Board's Statement 'Half-Yearly Financial Reports'; and

· The interim management report includes a fair review of the information required by The Financial Conduct Authority's ('FCA') Disclosure and Transparency Rule 4.2.7 R of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

· The interim management report includes a fair review of the information concerning related parties transactions as required by the Disclosure and Transparency Rule 4.2.8 R.

 

Colin Clark

Chairman

 

24 September 2021

 

 

Enquiries:

 

For further information, please contact:

 

Allianz Global Investors GmbH, UK Branch

Stephanie Carbonneil

Head of Investment Trusts

Tel: 020 3246 7256

 

Investment Manager's Review

Economic and Market Background

The progress of the COVID-19 pandemic continued to drive activity in the economy and financial markets during the first half of year, just as it did last year. The vaccine rollout in most of the Western world allowed governments to gradually lift restrictions on behaviour, such as social distancing. However, new mutations of the virus, in particular the Delta variant, affected progress and led to some reversals of policy along the way. The UK lifted most of the remaining domestic restrictions in mid-July, although foreign travel was still heavily impacted.

Economic activity rebounded rapidly, from a depressed base, with very strong annualised growth. Second quarter GDP growth in the UK was estimated at 4.8%. Many companies reported a strong recovery compared to a period heavily affected by lockdowns. As company profitability improved, a large number of businesses increased dividend pay-outs or resumed dividend payments that had been suspended last year, although total dividend payments remained below 2019 levels.

Inflationary pressures started to build, due to accelerating demand growth, industrial bottlenecks, logistical problems, rising commodity costs and some labour shortages. The UK consumer price index rose to 2.5% in June, above the Bank of England's 2% target, from well below 1% at the start of the year.

 

Equity markets made strong progress on the back of recovering economic conditions. The FTSE All-Share Index in the UK produced a total return, including income, of 12.6%, with smaller companies and many overseas markets performing even better. Rising inflationary pressures raised the prospect of earlier than expected interest rate increases, pushing up government bond yields significantly in the first quarter, and forcing government bond prices downwards, although this partially reversed in the second quarter.

 

Within the stock market, cyclical sectors that benefit from a recovering economy, and financials that benefit from rising interest rate expectations, generally performed best, including industrial transportation, mining and construction. However, the defensive beverages sector also performed well. Most other defensive sectors underperformed, including personal care, electricity, food, tobacco and telecommunications.

 

Investment Performance

Merchants' NAV rose significantly in the first half of the year, due to a combination of the rising stock market, outperformance from the investment portfolio and the impact of financial gearing, which amplifies returns in either direction. A full attribution of NAV returns is shown on page 8 of the printed report. In this section we explain the performance of the investment portfolio compared to the FTSE All-Share Index benchmark.

 

The portfolio outperformed significantly in the first half, with a total return of 16.2%, compared to a return of 12.6% for the FTSE All-Share Index. Most of the outperformance was driven by individual stock selection, although there was some benefit from industry selection, with a low exposure to the weak personal care sector helping relative performance. The table shows the top ten positive and negative contributors to relative performance.

 

Many of the top ten positive contributors were companies that benefit from economic recovery, rising financial markets and increasing interest rate expectations. These included recruitment company SThree, wealth and asset managers St James's Place and Man Group, Barclays bank and the building products company Tyman. The gambling company Entain, which was last year's strongest performance contributor, continued to outperform on the back of the rapidly growing US online betting market. BAE Systems also outperformed, supported by strong operating results. Relative performance also benefited from not owning certain shares that underperformed and held back the overall index return. Most notable were the household and personal care companies Unilever and Reckitt Benckiser, which were annualising an exceptional growth period and also faced rising commodity costs. London Stock Exchange's shares also fell back, as investors worried about the costs of integrating a large acquisition.

 

There were fewer significant negative stock contributors, but they typically reflected the same themes. Defensive companies that underperformed included the utility company SSE, telecommunications company Vodafone, reinsurer SCOR and drink company Stock Spirits. Diversified Energy also underperformed. Relative returns were also adversely affected by not owning certain cyclical companies which appreciated, including the commodity producers, Anglo American and Glencore, Lloyds Banking Group and plant hire company Ashtead. The remaining top ten negative contributor, also not owned in the portfolio, was the global spirits business Diageo, which outperformed despite its defensive characteristics.

 

 

Portfolio Changes

In a calmer economic environment, investment activity returned to a more normal pattern, after a heightened level of activity last year. Most portfolio transactions reflected individual company circumstances, however there was one structural change. The Merchants Trust was originally established in the nineteenth century to invest in overseas securities, such as railroad bonds in the USA. However, in recent years the portfolio has been exclusively invested in equities listed in the UK. Whilst UK listed companies provide a high degree of geographic diversification of their underlying activities, the universe of higher yielding UK companies has become more concentrated, especially during the pandemic. As explained in the annual report, the directors have now allowed an allocation of up to 10% of the portfolio in overseas listed shares, in order to provide greater diversification of investments and particularly income.

 

We added four European listed shares, representing just over 4% of the total portfolio. We added two reinsurance companies, Swiss Re and SCOR. We believe that this is an attractive industry, benefiting from a cyclical increase in insurance pricing, after a period of heavy losses. The shares are modestly valued, pay attractive dividend yields and their prospects are largely uncorrelated to economic or stock market cycles. Within the pharmaceutical sector, we introduced a holding in Sanofi, a diversified business with activities spanning pharmaceuticals, vaccines and consumer health. It has good growth prospects and trades on a very reasonable valuation, as the whole sector has de-rated in recent months. Finally, we bought a position in TotalEnergies to diversify the energy sector exposure away from the two large UK integrated energy companies, BP and Shell. TotalEnergies has made good progress along a path to significantly reducing its exposure to oil products by 2030, whilst growing its renewables & electricity and LNG operations. It has been managing this transition whilst also paying a progressive dividend, in contrast to many peers.

 

There were four other additions to the portfolio. Tesco, the UK's largest food retailer, also has a leading position in online food delivery and wholesaling to independent retailers and the catering industry. Despite resilient trading during the pandemic, and a refocusing of the business on key geographies, the shares have lagged behind the broader stock market, providing an attractive entry point. The investment case reflects the company's strong underlying cash generation and the opportunity to gain share in the fragmented catering and wholesale channels.

 

Relx is a leading provider of science, medical, legal, risk and other information and services to professional and business customers. The company has a good record of growth across its operations, which could accelerate as the business mix improves, and it also stands to benefit from a recovery in the exhibitions business, which was heavily impacted last year. After a period of underperformance, we were able to buy the shares at an unusually attractive level for the quality of the business.

 

Drax, historically the UK's largest coal fired power station, has transitioned into a 100% renewable power generator, operating biomass and hydro-electric generation assets, as well as producing wood pellets for biomass energy production. The company is hoping to agree a subsidy regime with the government to allow bio-energy carbon capture and storage (BECCS) which could turn Drax into a major "carbon negative" generator and could be critical in helping the UK become carbon neutral as a nation. This is a high-profile political project, which could represent significant upside for the business and in our view, was not reflected in the share price.

 

The final new holding is a modest investment in Duke Royalty, which provides royalty finance to a number of small businesses. This specialist financing can be attractive to borrowers as there are no "bullet" payments and no dilution of equity ownership. Duke's and the borrower's interests are aligned by payments that rise and fall, to a limited extent, in relation to the growth of the business. This allows Duke to make high returns from the royalty stream and a premium if the financing is repaid early. There was an attractive entry point into this business coming out of the pandemic, with Duke having demonstrated the resilience of its model through a particularly tough period.

 

Apart from these new holdings, the main purchase in the period was a significant addition to Vodafone as we switched out of BT within the telecommunications sector. BT was one of five holdings sold completely. Although we had not owned BT for long, the shares had performed well, closing much of the valuation opportunity, and we saw more potential in Vodafone.

 

Two shares were sold after strong share price gains had taken them up to fair value. CRH had benefited from improving prospects for infrastructure spending and strong operational performance. Kin & Carta had been completely transformed from a print services business to a digital transformation company over a period of years. The shares responded to this change, after some challenges, with an exceptional gain over the last 12 months.

 

 

We also exited the remaining position in Standard Life Aberdeen, having sold much of the investment last year. The company has successfully realised value by selling stakes in listed subsidiaries, but the operational turnaround of the business has been more challenging. Whilst there remains potential value in the company, we decided to divest, in order to fund higher conviction positions. Also, we sold the remaining position in the shopping centre owner, Hammerson. Whilst this has been a disappointing investment overall, as we had underestimated the industry's structural pressures, which were exacerbated by the pandemic, the shares have recovered well since we supported the rights issue last summer.

 

Other than these complete disposals, we reduced exposure to a number of shares, typically where strong performance had moved them closer to fair value and therefore we could only justify a smaller investment. The most significant of these were Barclays bank, the gambling company Entain and household products company PZ Cussons.

 

Outlook

The UK and major world economies are expected to continue their recovery. Growth remains vulnerable to restrictions on activity, in response to new variants of the COVID-19 virus and further waves of infection, but a high level of vaccination, especially in the UK, should mitigate this risk. Government and central bank policy remains supportive of the economy, although rising inflationary pressures could lead to higher interest rates down the road.

 

At the end of July, the UK stock market was almost back at the level it reached before the pandemic. However, the UK remains one of the cheapest major countries, having underperformed most European and US markets significantly since the Brexit referendum in 2016. Furthermore, there remains a high level of dispersion, with many shares trading on very modest valuations. As the pandemic has only had a limited impact on the longer-term prospects for most industries, this set of circumstances has created interesting investment opportunities. The low valuations of many fundamentally sound companies in the UK have not gone unnoticed. There has been a large number of takeover bids in the UK this year, typically from private equity investors or other corporations, and often at substantial premiums to the prevailing share price. If the stock market fails to fairly price companies, we can expect more of these bid approaches.

 

The high dispersion of UK company valuations has created a good environment for stock picking. Merchants holds a portfolio of fundamentally sound businesses, trading on attractive valuations, where we see supportive structural trends or other themes. The portfolio is diversified across industries, geographic end markets and degrees of economic sensitivity. We believe that this portfolio is capable of delivering a level of income and long term capital growth in line with Merchants' objectives.

 

 

Simon Gergel

Allianz Global Investors

 

THE MERCHANTS TRUST PLC

 

Twenty Largest Equity Holdings as at 31 July 2021

 

 

 

 

 

 

 

 

 

 

Value

 

% of

 

Benchmark

 

 

Name

£'000s

 

Holdings

 

Weightings

 

Principal Activities

 

 

 

 

 

 

 

 

GlaxoSmithKline

39,432

 

5.32

 

2.90

 

Pharmaceuticals & Biotechnology

Imperial Brands

35,929

 

4.84

 

0.60

 

Tobacco

British American Tobacco

32,166

 

4.34

 

2.53

 

Tobacco

BAE Systems

27,619

 

3.72

 

0.77

 

Aerospace & Defence

National Grid

25,179

 

3.39

 

1.36

 

Gas, Water & Multiutilities

Royal Dutch Shell B

25,106

 

3.39

 

2.18

 

Oil, Gas & Coal

SSE

24,935

 

3.36

 

0.62

 

Electricity

Vodafone Group

24,826

 

3.35

 

1.35

 

Telecommunications Service Providers

St. James's Place

24,194

 

3.26

 

0.35

 

Investment Banking & Brokerage

WPP

23,948

 

3.23

 

0.45

 

Media

BP

23,905

 

3.22

 

2.38

 

Oil, Gas & Coal

Legal & General

21,827

 

2.94

 

0.64

 

Life Insurance

Man Group

21,651

 

2.92

 

0.12

 

Investment Banking & Brokerage

IG Group Holdings

21,198

 

2.86

 

0.13

 

Investment Banking & Brokerage

Tate & Lyle

19,921

 

2.69

 

0.14

 

Food Producers

Redrow

19,803

 

2.67

 

0.06

 

Household Goods & Home Construction

Tyman

18,733

 

2.53

 

0.03

 

Construction & Materials

Barclays

18,493

 

2.49

 

1.22

 

Banks

Keller

16,280

 

2.20

 

0.03

 

Construction & Materials

BHP

15,847

 

2.14

 

2.00

 

Industrial Metals & Mining

 

 

 

 

 

 

 

 

480,992

 

64.86

 

 

 

 

 

 

 

Portfolio Analysis as at 31 July 2021

 

 

Sector

 

 

Value

£'000s

% Held

Benchmark weighting

 

 

 

 

 

Financials

 

146,986

20.22

17.95

Industrials

 

134,734

18.54

13.72

Consumer Staples

 

117,064

16.10

15.49

Consumer Discretionary

 

108,005

14.86

12.81

Energy

 

68,071

9.36

7.32

Utilities

 

64,648

8.89

3.00

Health Care

 

48,324

6.65

10.48

Telecommunications

 

24,826

3.42

2.24

Basic Materials

 

18,686

2.57

10.57

Real Estate

 

10,306

1.42

3.42

Technology

 

-

-

3.00

Net current liabilities

 

(14,764)

(2.03)

 

 

 

726,886

100.00

 

 

** Total Assets include current liabilities

 

 

 

THE MERCHANTS TRUST PLC

 

Summary of Unaudited Results

 

INCOME STATEMENT

For the six months ended 31 July 2021

 

 

 

 

Revenue

Capital

Total Return

 

£'000s

£'000s

£'000s

 

 

 

(Note 1)

Gains on investments held at fair value through profit or loss

-

88,533

88,533

Losses on foreign currencies

-

(2)

(2)

Income from investments

17,434

-

17,434

Other income

715

-

715

Investment management fee

(442)

(822)

(1,264)

Administrative expenses

(468)

(1)

(469)

Profit before finance costs and taxation

17,239

87,708

104,947

Finance costs: interest payable and similar charges

(590)

(1,048)

(1,638)

 

 

 

 

Profit on ordinary activities before taxation

16,649

86,660

103,309

Taxation

(288)

-

(288)

 

 

 

 

Profit after taxation attributable to ordinary shareholders

16,361

86,660

103,021

 

 

 

Earnings per ordinary share (Note 4)

 

 

 

(basic and diluted)

13.33p

70.58p

83.91p

 

 

 

 

 

 

 

 

BALANCE SHEET

£'000s

As at 31 July 2021

 

 

Fixed Assets

 

Investments held at fair value through profit or loss

 741,650

Net current liabilities

(14,764)

Total assets less current liabilities

726,886

Creditors: amounts falling due after more than one year

(66,728)

Total net assets

660,158

 

 

Called up share capital

31,182

Share premium account

102,192

Capital redemption reserve

293

Capital reserve

504,599

Revenue reserve

21,892

Equity shareholders' funds

660,158

 

 

Net asset value per ordinary share

529.3p

 

 

The net asset value as at 31 July 2021 is based on 124,729,887 ordinary shares.

 

 

 

 

 

INCOME STATEMENT

For the six months ended 31 July 2020

 

 

 

 

Revenue

Capital

Total Return

 

£'000s

£'000s

£'000s

 

 

 

(Note 1)

Losses on investments held at fair value through profit or loss

-

(194,751)

(194,751)

Losses on foreign currencies

-

(7)

(7)

Income from investments

11,624

-

11,624

Other income

424

-

424

Investment management fee

(345)

(641)

(986)

Administrative expenses*

(665)

(1)

(666)

Profit (loss) before finance costs and taxation

11,038

(195,400)

(184,362)

Finance costs: interest payable and similar charges

(629)

(1,105)

(1,734)

 

 

 

 

Profit (loss) on ordinary activities before taxation

10,409

(196,505)

(186,096)

Taxation

(19)

-

(19)

 

 

 

 

Profit (loss) after taxation attributable to ordinary shareholders

10,390

(196,505)

(186,115)

 

 

 

Earnings (loss) per ordinary share (Note 4)

 

 

 

(basic and diluted)

8.92p

(168.76p)

(159.84p)

 

 

 

 

 

 

 

 

BALANCE SHEET

£'000s

As at 31 July 2020

 

 

Fixed Assets

 

Investments held at fair value through profit or loss

 518,067

Net current liabilities

(6,970)

Total assets less current liabilities

511,097

Creditors: amounts falling due after more than one year

(66,678)

Total net assets

444,419

 

 

Called up share capital

 29,724

Share premium account

 75,984

Capital redemption reserve

 293

Capital reserve

 311,604

Revenue reserve

 26,814

Equity shareholders' funds

444,419

 

 

Net asset value per ordinary share

373.8p

 

 

The net asset value is based on 118,894,887 ordinary shares in issue at 31 July 2020.

 

*Administrative expenses in 2020 include the London Stock Exchange block listing fee of £155,000.

 

 

 

 

 

 

 

BALANCE SHEET

£'000s

As at 31 January 2021

 

 

Fixed Assets

 

Investments at fair value through profit or loss

638,235

Net current liabilities

(16,814)

Total assets less current liabilities

621,421

Creditors: amounts falling due after more than one year

(66,704)

Total net assets

554,717

 

 

Called up share capital

 30,246

Share premium account

84,137

Capital redemption reserve

 293

Capital reserve

 417,939

Revenue reserve

 22,102

Equity shareholders' funds

554,717

 

 

Net asset value per ordinary share

458.5p

 

 

The net asset value as at 31 January 2021 is based on 120,984,887 ordinary shares.

 

 

 

THE MERCHANTS TRUST PLC

 

STATEMENT OF CHANGES IN EQUITY

 

 

 

 

 

Called Up

Share

Capital

£'000s

 

Share Premium

Account

£'000s

 

Capital Redemption Reserve

£'000s

 

 

Capital

Reserve

£'000s

 

 

Revenue Reserve

£'000s

 

 

 

Total

£'000s

 

 

 

 

 

 

 

Six months ended 31 July 2021

 

 

 

 

 

 

Net assets at 1 February 2021

30,246

84,137

293

417,939

22,102

554,717

 

 

 

 

 

 

 

Revenue profit

-

-

-

 -

16,361

16,361

 

 

 

 

 

 

Dividends on ordinary shares (Note 3)

-

-

-

 -

(16,571)

(16,571)

 

 

 

 

 

 

 

Capital profit

-

-

-

86,660

-

86,660

 

 

 

 

 

 

 

Shares issued during the period

936

18,055

-

-

-

18,991

 

 

 

 

 

 

 

Net assets at 31 July 2021

31,182

102,192

293

504,599

21,892

660,158

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended 31 July 2020

 

 

 

 

 

 

Net assets at 1 February 2020

28,220

54,093

293

508,109

 31,820

622,535

 

 

 

 

 

 

 

Revenue profit

-

-

-

 -

10,390

10,390

 

 

 

 

 

 

Dividends on ordinary shares (Note 3)

-

-

-

 -

(15,443)

(15,443)

 

 

 

 

 

 

 

Unclaimed Dividends

-

-

-

-

47

47

 

 

 

 

 

 

 

Capital loss

-

-

-

(196,505)

-

(196,505)

 

 

 

 

 

 

 

Shares issued during the period

1,504

21,891

-

-

-

23,395

 

 

 

 

 

 

 

Net assets at 31 July 2020

29,724

75,984

293

311,604

26,814

444,419

 

 

THE MERCHANTS TRUST PLC

 

CASH FLOW STATEMENT

 

 

 

Six Months

ended 31 July 2021

 

Six Months

ended 31 July 2020

 

 

£'000s

 

£'000s

 

Operating activities

 

 

 

 

Profit (loss) before finance costs and taxation

104,947

 

(184,362)

 

Less: (Gains) losses on investments at fair value

(88,138)

 

195,343

 

Add: (Losses) on foreign currency

2

 

7

 

Purchase of fixed asset investments held at fair value through profit or loss

(104,954)

 

(131,577)

 

Sales of fixed asset investments held at fair value through profit or loss

94,207

 

121,259

 

Transaction costs

(395)

 

(592)

 

Increase in other receivables

(1,421)

 

(955)

 

Increase (decrease) in other payables

13

 

(285)

 

Less: Overseas tax suffered

(288)

 

(19)

 

 

 

 

 

 

 

 

 

 

 

Net cash (outflow) inflow from operating activities

3,973

 

(1,181)

 

 

 

 

 

 

Financing activities

 

 

 

 

Interest paid

(1,599)

 

(1,712)

 

Dividends paid on cumulative preference stock

(22)

 

(21)

 

Dividends paid on ordinary shares

(16,571)

 

(15,443)

 

Unclaimed dividends

-

 

 47

 

Share issue proceeds

17,983

 

25,566

 

 

 

 

 

 

Net cash (outflow) inflow from financing activities

(209)

 

8,437

 

 

 

 

 

 

Increase in cash and cash equivalents

3,764

 

7,256

 

 

 

 

 

 

Cash and cash equivalents at the start of the period

 6,623

 

10,546

 

Effect of foreign exchange rates

(2)

 

(7)

 

Cash and cash equivalents at the end of the period

 10,385

 

17,795

 

 

 

 

 

 

Composed of:

 

 

 

 

Cash at bank

10,385

 

17,795

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THE MERCHANTS TRUST PLC

 

Notes to the Financial Statements

 

Note 1 - Financial Statements

 

The half-yearly financial report has been neither audited nor reviewed by the company's auditors. The financial information for the year ended 31 January 2021 has been extracted from the statutory financial statements for that year which have been delivered to the Registrar of Companies. The auditors' report on those financial statements was unqualified and did not contain a statement under section 498 of the Companies Act 2006.

 

The total return column of the Income Statement is the profit and loss account of the company.

 

All revenue and capital items derive from continuing operations. No operations were acquired or discontinued in the period.

 

Allianz Global Investors GmbH, UK Branch ('AllianzGI'), acts as Investment Manager to the company. Details of the services and fee arrangements are given in the latest annual report of the company, which is available on the company's website at www.merchantstrust.co.uk.

 

 

Note 2 - Accounting Policies

 

The company presents its results and positions under 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (FRS 102), which forms part of revised Generally Accepted Accounting Practice (New UK GAAP) issued by the Financial Reporting Council.

 

The condensed set of financial statements has been prepared on a going concern basis in accordance with FRS 102 and FRS 104, 'Interim Financial Reporting' and the Statement of Recommended Practice - 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('SORP'). The impact of COVID-19 has been thoroughly considered and the directors have concluded that there are no material uncertainties related to going concern. They have also been prepared on the assumption that approval as an investment trust will continue to be granted.

 

The interim financial statements and the net asset value per share figures have been prepared in accordance with FRS 102 using the same accounting policies as the preceding annual accounts.

 

Note 3 - Dividends on Ordinary Shares

 

Dividends paid on ordinary shares in respect of earnings for each period are as follows:

 

 

Six months

 

Six months

 

 

ended

 31 July 2021

 

ended

31 July 2020

 

 

£'000s

 

£'000s

 

 

 

 

 

 

Third quarterly dividend 6.8p paid 16 March 2021 (2020: 6.8p)

8,227

 

7,649

 

Final dividend 6.8p paid 18 May 2021 (2020: Final 6.8p)

8,344

 

 7,794

 

 

16,571

 

15,443

 

 

In accordance with FRS 102 section 32 'Events After the End of the Reporting Period', dividends payable at the period end have not been recognised as a liability. Details of these dividends are set out below.

 

 

 

Six months

 

Six months

 

 

ended

31 July 2021

 

ended

31 July 2020

 

 

£'000s

 

£'000s

 

 

 

 

 

 

First quarterly dividend 6.8p paid 20 August 2021 (2020 - 6.8p)

8,451

 

 8,085

 

Second quarterly dividend 6.8p payable 11 November 2021 (2020 - 6.8p)

8,482

 

 8,085

 

 

16,933

 

16,170

 

 

The dividends above are based on the number of shares in issue at the period end. However, the dividend payable will be based upon the number of shares in issue on the record date and will reflect any purchase or cancellation of shares by the company settled subsequent to the period end.

Note 4 - Earnings per Ordinary Share

 

The earnings per ordinary share is based on a weighted number of ordinary shares 122,779,445 (31 July 2020: 116,440,988) in issue.

 

Note 5 - Fair Value Hierarchy

 

Investments and derivative financial instruments are designated as held at fair value through profit or loss in accordance with FRS 102 sections 11 and 12.

 

FRS 102 fair value hierarchy disclosures (March 2016) sets out three fair value levels.

 

Level 1: The unadjusted quoted price in an active market for identical assets or liabilities that the entity can access at the measurement date.

 

Level 2: Inputs other than quoted prices included within Level 1 that are observable (i.e., developed using market data) for the asset or liability, either directly or indirectly.

 

Level 3: Inputs are unobservable (i.e., for which market data is unavailable) for the asset or liability.

 

With the exception of those financial liabilities measured at amortised cost, all other financial assets and financial liabilities are either carried at their fair value or the balance sheet amount is a reasonable approximation of their fair value.

 

 

As at 31 July 2021, the financial assets at fair value through profit and loss of £741,637,000 (31 July 2020: £517,938,000; 31 January 2021: £638,182,000) are categorised as follows:

 

Level 1

 

Level 2

 

Level 3

 

Total

 

£'000s

 

£'000s

 

£'000s

 

£'000s

Financial assets at fair value through profit or loss at 31 July 2021

 

 

 

 

 

 

 

Equity investments

741,646

 

-

 

-

 

741,646

Financial instruments

-

 

-

 

 4

 

 4

Derivative financial instruments - written call options

-

 

(13)

 

-

 

 (13)

 

741,646

 

 (13)

 

4

 

741,637

 

 

 

 

 

 

 

 

Financial assets at fair value through profit or loss at 31 July 2020

 

 

 

 

 

 

 

Equity investments

518,063

 

-

 

-

 

518,063

Financial instruments

-

 

-

 

 4

 

 4

Derivative financial instruments - written call options

-

 

(129)

 

-

 

 (129)

 

518,063

 

 (129)

 

4

 

517,938

 

 

 

 

 

 

 

 

Financial assets at fair value through profit or loss at 31 January 2021

 

 

 

 

 

 

 

Equity investments

638,231

 

-

 

-

 

638,231

Financial instruments

-

 

-

 

4

 

4

Derivative financial instruments - written call options

-

 

(53)

 

-

 

(53)

 

638,231

 

(53)

 

4

 

638,182

 

For exchange listed equity investments the quoted price is either the bid price or the last traded price depending on the convention of the relevant exchange. For written options the value of the option is marked to market based on traded prices. Financial instruments valued using valuation techniques level 3 have, in the absence of relevant trading prices or market data, been valued based on the directors' best estimate.

 

Note 6 - Status of the Company

 

The company applied for and was accepted as an approved investment trust for accounting periods commencing on or after 1 February 2013, subject to it continuing to meet eligibility conditions at section 1158 Corporation Taxes Act 2010 and the on-going requirements for approved companies in Chapter 3 Part 2 Investment Trust (Approved Company) (Tax) Regulations 2011 (Statutory Instrument 2011/2999).

 

Note 7 - Transactions with the Investment Manager and related parties

 

As disclosed in the annual report, the existence of an independent board of directors demonstrates that the company is free to pursue its own financial and operating policies and therefore, under FRS 8: Related Party Disclosures, the investment manager is not considered to be a related party. The company's related parties are its directors.

 

There are no other identifiable related parties as at 31 July 2021, 31 July 2020 and 31 January 2021.

 

The half-yearly financial report will be sent to shareholders at the end of September 2021 and will be available to members of the public from the company's registered office at 199 Bishopsgate, London EC2M 3TY or by calling the Investor Services Helpline on 0800 389 4696.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DKQBNOBKDKCB
Date   Source Headline
3rd May 20241:30 pmRNSNet Asset Value(s)
2nd May 20242:16 pmRNSNet Asset Value(s)
1st May 202412:40 pmRNSNet Asset Value(s)
1st May 202412:13 pmRNSTotal Voting Rights
30th Apr 202412:58 pmRNSNet Asset Value(s)
30th Apr 202410:04 amEQSEdison issues update on The Merchants Trust (MRCH): Celebrating its 135th anniversary
29th Apr 202412:44 pmRNSNet Asset Value(s)
26th Apr 20241:51 pmRNSNet Asset Value(s)
25th Apr 202412:53 pmRNSNet Asset Value(s)
24th Apr 20241:51 pmRNSNet Asset Value(s)
23rd Apr 202412:44 pmRNSNet Asset Value(s)
22nd Apr 20241:13 pmRNSNet Asset Value(s)
19th Apr 202412:45 pmRNSNet Asset Value(s)
18th Apr 20241:24 pmRNSNet Asset Value(s)
17th Apr 20242:30 pmRNSNet Asset Value(s)
16th Apr 20244:28 pmRNSDirector/PDMR Shareholding
16th Apr 20241:10 pmRNSNet Asset Value(s)
15th Apr 202412:21 pmRNSNet Asset Value(s)
12th Apr 20241:11 pmRNSNet Asset Value(s)
11th Apr 20241:01 pmRNSNet Asset Value(s)
10th Apr 202412:55 pmRNSNet Asset Value(s)
9th Apr 20241:20 pmRNSNet Asset Value(s)
8th Apr 202412:43 pmRNSNet Asset Value(s)
5th Apr 20241:57 pmRNSNet Asset Value(s)
5th Apr 20241:26 pmRNSDividend Declaration
5th Apr 202410:00 amRNSGeographical Distribution
4th Apr 20244:41 pmRNSTotal Voting Rights
4th Apr 20244:38 pmRNSTop 10 Holdings
4th Apr 20243:24 pmRNSNet Asset Value(s)
4th Apr 20249:45 amRNSListing Rule 15.6.8
4th Apr 20247:00 amRNSFinal Results
3rd Apr 20241:57 pmRNSNet Asset Value(s)
2nd Apr 20244:00 pmRNSNet Asset Value(s)
28th Mar 20241:15 pmRNSNet Asset Value(s)
27th Mar 202411:53 amRNSNet Asset Value(s)
26th Mar 202412:31 pmRNSNet Asset Value(s)
25th Mar 202412:10 pmRNSNet Asset Value(s)
22nd Mar 20244:31 pmRNSBlock listing Interim Review
22nd Mar 202412:52 pmRNSNet Asset Value(s)
21st Mar 202412:19 pmRNSNet Asset Value(s)
20th Mar 202412:41 pmRNSNet Asset Value(s)
19th Mar 20241:04 pmRNSNet Asset Value(s)
18th Mar 202412:49 pmRNSNet Asset Value(s)
15th Mar 20241:06 pmRNSNet Asset Value(s)
14th Mar 20241:30 pmRNSNet Asset Value(s)
13th Mar 20241:02 pmRNSNet Asset Value(s)
12th Mar 20241:01 pmRNSNet Asset Value(s)
11th Mar 202412:29 pmRNSNet Asset Value(s)
8th Mar 20241:24 pmRNSNet Asset Value(s)
7th Mar 20243:25 pmRNSClosed Period

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.